Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, L.
Right arrow Articles by Champoux, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, L.
Right arrow Articles by Champoux, J. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 13, Issue of March 29, 1996 pp. 7602-7608
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Domain Organization of Human Topoisomerase I

(Received for publication, October 12, 1995; and in revised form, January 21, 1996)

Lance Stewart Gregory C. Ireton James J. Champoux

Using limited proteolysis, we show that the domain boundaries of human topoisomerase I closely parallel those predicted from sequence comparisons with other cellular Topo I enzymes. The enzyme is comprised of (i) an NH(2)-terminal domain (24 kDa), which is known to be dispensable for activity, (ii) the core domain (54 kDa), (iii) a linker region (3 kDa), and (iv) the COOH-terminal domain (10 kDa), which contains the active site tyrosine. The highly conserved core and COOH-terminal domains are resistant to proteolysis, while the unconserved NH(2)-terminal and linker domains are sensitive. Noncovalent binding of Topo I to plasmid DNA or to short duplex oligonucleotides decreases the sensitivity of the linker to proteolysis by approximately a factor of 10 but has no effect on proteolysis of the NH(2)-terminal domain. When the enzyme is covalently complexed to an 18 base pair single-stranded oligonucleotide, the linker region is sensitive to proteolysis whether or not duplex DNA is present. The net positive charge of the linker domain suggests that at a certain point in catalysis the linker may bind directly to DNA. Further, we show that limited subtilisin cleavage can generate a mixture of 60-kDa core and 10-kDa COOH-terminal fragments, which retain a level of topoisomerase activity that is nearly equal to undigested control samples, presumably because the two fragments remain associated after proteolytic cleavage. Thus, despite its potential role in DNA binding, the linker domain (in addition to the NH(2)-terminal domain) appears to be dispensable for topoisomerase activity. Finally, the limited proteolysis pattern of the human enzyme differs substantially from the limited proteolysis pattern of the vaccinia viral Topo I, indicating that the two enzymes belong to separate eukaryotic topoisomerase I subfamilies.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
N. M. Baker, R. Rajan, and A. Mondragon
Structural studies of type I topoisomerases
Nucleic Acids Res., February 1, 2009; 37(3): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Palle, L. Pattarello, M. van der Merwe, C. Losasso, P. Benedetti, and M.-A. Bjornsti
Disulfide Cross-links Reveal Conserved Features of DNA Topoisomerase I Architecture and a Role for the N Terminus in Clamp Closure
J. Biol. Chem., October 10, 2008; 283(41): 27767 - 27775.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Chillemi, I. D'Annessa, P. Fiorani, C. Losasso, P. Benedetti, and A. Desideri
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations
Nucleic Acids Res., October 1, 2008; 36(17): 5645 - 5651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. van der Merwe and M.-A. Bjornsti
Mutation of Gly721 Alters DNA Topoisomerase I Active Site Architecture and Sensitivity to Camptothecin
J. Biol. Chem., February 8, 2008; 283(6): 3305 - 3315.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. F. Frohlich, C. Veigaard, F. F. Andersen, A. K. McClendon, A. C. Gentry, A. H. Andersen, N. Osheroff, T. Stevnsner, and B. R. Knudsen
Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal
Nucleic Acids Res., September 25, 2007; 35(18): 6170 - 6180.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
I. Har-Vardi, R. Mali, M. Breietman, Y. Sonin, S. Albotiano, E. Levitas, G. Potashnik, and E. Priel
DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties
Hum. Reprod., August 1, 2007; 22(8): 2183 - 2189.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Chillemi, A. Bruselles, P. Fiorani, S. Bueno, and A. Desideri
The open state of human topoisomerase I as probed by molecular dynamics simulation
Nucleic Acids Res., May 14, 2007; 35(9): 3032 - 3038.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Losasso, E. Cretaio, K. Palle, L. Pattarello, M.-A. Bjornsti, and P. Benedetti
Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell Lethality
J. Biol. Chem., March 30, 2007; 282(13): 9855 - 9864.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann
NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity
Cancer Res., January 15, 2007; 67(2): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Ganguly, B. B. Das, N. Sen, A. Roy, S. B. Dasgupta, and H. K. Majumder
'LeishMan' topoisomerase I: an ideal chimera for unraveling the role of the small subunit of unusual bi-subunit topoisomerase I from Leishmania donovani
Nucleic Acids Res., December 4, 2006; 34(21): 6286 - 6297.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. Fiorani, G. Chillemi, C. Losasso, S. Castelli, and A. Desideri
The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant
Nucleic Acids Res., October 6, 2006; 34(18): 5093 - 5100.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yang, C.-T. Hsu, C.-Y. Ting, L. F. Liu, and J. Hwang
Assembly of a Polymeric Chain of SUMO1 on Human Topoisomerase I in Vitro
J. Biol. Chem., March 24, 2006; 281(12): 8264 - 8274.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Marchand, S. Antony, K. W. Kohn, M. Cushman, A. Ioanoviciu, B. L. Staker, A. B. Burgin, L. Stewart, and Y. Pommier
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
Mol. Cancer Ther., February 1, 2006; 5(2): 287 - 295.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Sari and I. Andricioaei
Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation
Nucleic Acids Res., November 27, 2005; 33(20): 6621 - 6634.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Chillemi, P. Fiorani, S. Castelli, A. Bruselles, P. Benedetti, and A. Desideri
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study
Nucleic Acids Res., June 8, 2005; 33(10): 3339 - 3350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. B. Das, N. Sen, S. B. Dasgupta, A. Ganguly, and H. K. Majumder
N-terminal Region of the Large Subunit of Leishmania donovani Bisubunit Topoisomerase I Is Involved in DNA Relaxation and Interaction with the Smaller Subunit
J. Biol. Chem., April 22, 2005; 280(16): 16335 - 16344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Yu, E. Khan, M. A. Khaleque, J. Lee, G. Laco, G. Kohlhagen, S. Kharbanda, Y.-C. Cheng, Y. Pommier, and A. Bharti
Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity
J. Biol. Chem., December 10, 2004; 279(50): 51851 - 51861.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Q. Hu, N. Fertig, T. A. Medsger Jr, and T. M. Wright
Molecular Recognition Patterns of Serum Anti-DNA Topoisomerase I Antibody in Systemic Sclerosis
J. Immunol., August 15, 2004; 173(4): 2834 - 2841.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. O. Christensen, H. U. Barthelmes, F. Boege, and C. Mielke
Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro
Nucleic Acids Res., December 15, 2003; 31(24): 7255 - 7263.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Roy, P. Trowbridge, Z. Yang, J. J. Champoux, and D. T. Simmons
The Cap Region of Topoisomerase I Binds to Sites near Both Ends of Simian Virus 40 T Antigen
J. Virol., September 15, 2003; 77(18): 9809 - 9816.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. Bodley, A. K. Chakraborty, S. Xie, C. Burri, and T. A. Shapiro
An unusual type IB topoisomerase from African trypanosomes
PNAS, June 24, 2003; 100(13): 7539 - 7544.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. Carey, S. J. Schultz, L. Sisson, T. G. Fazzio, and J. J. Champoux
DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein
PNAS, May 13, 2003; 100(10): 5640 - 5645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Villa, A. R. Otero Marcos, R. M. Reguera, R. Balana-Fouce, C. Garcia-Estrada, Y. Perez-Pertejo, B. L. Tekwani, P. J. Myler, K. D. Stuart, M.-A. Bjornsti, et al.
A Novel Active DNA Topoisomerase I in Leishmania donovani
J. Biol. Chem., January 31, 2003; 278(6): 3521 - 3526.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Rallabhandi, K. Hashimoto, Y.-Y. Mo, W. T. Beck, P. K. Moitra, and P. D'Arpa
Sumoylation of Topoisomerase I Is Involved in Its Partitioning between Nucleoli and Nucleoplasm and Its Clearing from Nucleoli in Response to Camptothecin
J. Biol. Chem., October 11, 2002; 277(42): 40020 - 40026.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D.-T. T. Lesher, Y. Pommier, L. Stewart, and M. R. Redinbo
8-Oxoguanine rearranges the active site of human topoisomerase I
PNAS, September 17, 2002; 99(19): 12102 - 12107.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
T. Takahashi, S. Matsuhara, M. Abe, and Y. Komeda
Disruption of a DNA Topoisomerase I Gene Affects Morphogenesis in Arabidopsis
PLANT CELL, September 1, 2002; 14(9): 2085 - 2093.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Yang and J. J. Champoux
Reconstitution of Enzymatic Activity by the Association of the Cap and Catalytic Domains of Human Topoisomerase I
J. Biol. Chem., August 16, 2002; 277(34): 30815 - 30823.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. T. Van Dross and M. M. Sanders
Molecular Characterization of Recombinant Pneumocystis carinii Topoisomerase I: Differential Interactions with Human Topoisomerase I Poisons and Pentamidine
Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2145 - 2154.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Mao, I. R. Mehl, and M. T. Muller
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status
PNAS, January 17, 2002; (2002) 22631899.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Soe, G. Dianov, H.-P. Nasheuer, V. A. Bohr, F. Grosse, and T. Stevnsner
A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro
Nucleic Acids Res., August 1, 2001; 29(15): 3195 - 3203.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
X. Zhang and F. Kiechle
Hoechst 33342-Induced Apoptosis is Associated with Decreased Immunoreactive Topoisomerase I and Topoisomerase I-DNA Complex Formation
Ann. Clin. Lab. Sci., April 1, 2001; 31(2): 187 - 198.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
A. Balestrazzi, A. Chini, G. Bernacchia, A. Bracci, G. Luccarini, R. Cella, and D. Carbonera
Carrot cells contain two top1 genes having the coding capacity for two distinct DNA topoisomerases I
J. Exp. Bot., December 1, 2000; 51(353): 1979 - 1990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. Chen, C.-L. Hwong, C.-H. Wang, and J. Hwang
Degradation of DNA Topoisomerase I by a Novel Trypsin-like Serine Protease in Proliferating Human T Lymphocytes
J. Biol. Chem., April 21, 2000; 275(17): 13109 - 13117.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Stewart, G. C. Ireton, and J. J. Champoux
A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay
J. Biol. Chem., November 12, 1999; 274(46): 32950 - 32960.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. L. Beretta, M. Binaschi, E. Zagni, L. Capuani, and G. Capranico
Tethering a Type IB Topoisomerase to a DNA Site by Enzyme Fusion to a Heterologous Site-selective DNA-binding Protein Domain
Cancer Res., August 1, 1999; 59(15): 3689 - 3697.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Komatani, M. Morita, N. Sakaizumi, K. Fukasawa, E. Yoshida, A. Okura, T. Yoshinari, and S. Nishimura
A New Mechanism of Acquisition of Drug Resistance by Partial Duplication of Topoisomerase I
Cancer Res., June 1, 1999; 59(11): 2701 - 2708.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. W. Trowbridge, R. Roy, and D. T. Simmons
Human Topoisomerase I Promotes Initiation of Simian Virus 40 DNA Replication In Vitro
Mol. Cell. Biol., March 1, 1999; 19(3): 1686 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Kampranis and A. Maxwell
Conformational Changes in DNA Gyrase Revealed by Limited Proteolysis
J. Biol. Chem., August 28, 1998; 273(35): 22606 - 22614.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W.-L. Shaiu and T.-s. Hsieh
Targeting to Transcriptionally Active Loci by the Hydrophilic N-Terminal Domain of Drosophila DNA Topoisomerase I
Mol. Cell. Biol., July 1, 1998; 18(7): 4358 - 4367.
[Abstract] [Full Text]


Home page
ScienceHome page
L. Stewart, M. R. Redinbo, X. Qiu, W. G. Hol, and J. J. Champoux
A Model for the Mechanism of Human Topoisomerase I
Science, March 6, 1998; 279(5356): 1534 - 1541.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. E. Jones, V. Dossonnet, E. Kuster, W. Hillen, J. Deutscher, and R. E. Klevit
Binding of the Catabolite Repressor Protein CcpA to Its DNA Target Is Regulated by Phosphorylation of its Corepressor HPr
J. Biol. Chem., October 17, 1997; 272(42): 26530 - 26535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. O. Petersen and S. Shuman
Histidine 265Is Important for Covalent Catalysis by Vaccinia Topoisomerase and Is Conserved in All Eukaryotic Type I Enzymes
J. Biol. Chem., February 14, 1997; 272(7): 3891 - 3896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Stewart, G. C. Ireton, L. H. Parker, K. R. Madden, and J. J. Champoux
Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I
J. Biol. Chem., March 29, 1996; 271(13): 7593 - 7601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. C. Ireton, L. Stewart, L. H. Parker, and J. J. Champoux
Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin
J. Biol. Chem., August 11, 2000; 275(33): 25820 - 25830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-Y. Mo, C. Wang, and W. T. Beck
A Novel Nuclear Localization Signal in Human DNA Topoisomerase I
J. Biol. Chem., December 22, 2000; 275(52): 41107 - 41113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Yang and J. J. Champoux
The Role of Histidine 632 in Catalysis by Human Topoisomerase I
J. Biol. Chem., January 5, 2001; 276(1): 677 - 685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lisby, J. R. Olesen, C. Skouboe, B. O. Krogh, T. Straub, F. Boege, S. Velmurugan, P. M. Martensen, A. H. Andersen, M. Jayaram, et al.
Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation*
J. Biol. Chem., June 1, 2001; 276(23): 20220 - 20227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-Y. Mo, Y. Yu, Z. Shen, and W. T. Beck
Nucleolar Delocalization of Human Topoisomerase I in Response to Topotecan Correlates with Sumoylation of the Protein
J. Biol. Chem., January 18, 2002; 277(4): 2958 - 2964.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Mao, I. R. Mehl, and M. T. Muller
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status
PNAS, February 5, 2002; 99(3): 1235 - 1240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement